Description
The AACR Career Development Awards to Foster Diversity and Inclusion in Cancer Research encourages and supports early-stage scientists engaged in cancer research. Proposed projects may be in basic, translational, or population sciences related research and must have direct applicability and relevance to the understanding, detection, diagnosis, interception, treatment, or prevention of cancer.
This grant provides $300,000 over three years for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborator, postdoctoral research fellows, graduate students (including tuition costs associated with graduate students’ education and training), research assistants; research/laboratory supplies; equipment; publication charges for manuscripts that pertain directly to the funded project; and other research expenses.
Although AACR does not publish a granular scoring rubric, competitive applications across its programs tend to share these characteristics (based on program descriptions and typical reviewer expectations in cancer research funding):
✅ 1) Scientific Innovation & High Impact
AACR explicitly funds research that advances understanding, prevention, detection, or treatment of cancer, including projects expected to influence clinical practice or future research directions. AACR
Predictor:
Identify a clear cancer biology problem or unmet clinical need.
Propose novel hypotheses, methods, or models that could substantially advance the field.
✅ 2) Strong Preliminary Data (When Expected)
For competitive mechanisms — especially independent research or career development awards — high-quality pilot data demonstrating feasibility and biological relevance is often a major differentiator. Trialect
Predictor:
Well-designed preliminary results that show your project can realistically succeed.
Data that support your key hypotheses and justify your approach.
✅ 3) Clear Translational Potential
AACR values work with a credible trajectory toward impact on patients (e.g., new targets, biomarkers, therapeutic approaches). Trialect
Predictor:
Describe how your findings could move from lab to clinic within a reasonable timeframe or enable future translational studies.
✅ 4) Explicit Cancer Relevance
This is fundamental: proposals must explicitly tie the science to cancer mechanisms, tumor biology, or clinical oncology challenges. Trialect
Predictor:
Ground hypotheses in established cancer pathways.
Justify model systems and readouts with respect to cancer biology or treatment.
✅ 5) Investigator Track Record & Environment
AACR reviewers consider the track record of productivity (especially first-author publications and progress in the field) and whether the applicant’s institution provides a supportive research environment. Trialect
Predictor:
Recent relevant publications and abstracts at major oncology meetings.
Clear institutional support (facilities, mentorship, collaborations).
✅ 6) Feasible, Focused Aims
Too many or overly ambitious aims can reduce a proposal’s chance of success, especially if they appear unrealistic within the grant term. Trialect
Predictor:
2–3 well-defined, achievable aims with clear decision points and milestones.
✅ 7) Strong Mentorship (for Early-Career Awards)
For fellowships and career development grants, detailed mentorship plans with established scientists signal high potential for growth and success. Trialect
Predictor:
Mentors with relevant expertise and a track record of guiding productive trainees.
✅ 8) Clear, Reviewer-Friendly Writing
Proposal clarity — including lucid hypotheses, logical experimental design, and straightforward presentation of expected outcomes — helps peer reviewers (often from diverse subfields) assess merit fairly.
Predictor:
Avoid jargon; write so that reviewers outside your specific niche can appreciate innovation and feasibility.
✅ 9) Alignment with Specific Grant Goals
AACR offers many distinct mechanisms — from basic research to diversity and inclusion awards. Each has unique priorities. AACR
Predictor:
Tailor your application to the specific goals of the mechanism you’re applying for (e.g., research focus, career stage, or diversity mission).
Here’s a checklist based on best practices for competitive cancer research grant proposals:
Before You Apply
✔ Review the program guidelines and eligibility thoroughly. AACR
✔ Contact program staff with any questions about fit.*
✔ Secure strong letters of support (especially for career awards).
Proposal Development
✔ Build compelling rationale with data and literature context.
✔ Define concise, hypothesis-driven aims.
✔ Justify methods, models, and sample sizes.
✔ Create a realistic timeline and budget.
✔ Highlight translational relevance.
Review Process Understanding
AACR’s grant review is peer-based, with experts evaluating scientific merit, feasibility, and significance — much like other competitive biomedical grant systems. Clear communication about why the science matters is essential. AACR
| Key Predictor | Why It Matters |
|---|---|
| Scientific innovation | AACR prioritizes breakthrough cancer science. AACR |
| Robust preliminary data | Bolsters feasibility and credibility. Trialect |
| Clear translational potential | Aligns research with patient impact. Trialect |
| Explicit cancer relevance | Fundamental to AACR’s mission. Trialect |
| Investigator track record | Signals ability to execute. Trialect |
| Focused, achievable aims | Prevents overreach. Trialect |
| Strong mentorship & environment | Important for early-career awards. Trialect |
Applicants must have a doctoral degree (including PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral or professional degree. Applicants cannot have clinical responsibilities.
At the start of the grant term on September 1, 2026, applicants must:
Sponsor Institute/Organizations: American Association for Cancer Research
Sponsor Type: Corporate/Non-Profit
Address: 615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404 USA
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 27, 2026
May 19, 2026
$300,000
Affiliation: American Association for Cancer Research
Address: 615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404 USA
Website URL: https://www.aacr.org/grants/aacr-career-development-awards-to-foster-diversity-and-inclusion/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.